33932 Federal Register / Vol. 63, No. 119 / Monday, June 22, 1998 / Notices

Unless otherwise noted, comments

regarding each of these applications

must be received at the Reserve Bank

indicated or the offices of the Board of

Governors not later than July 16, 1998.

A. Federal Reserve Bank of Boston

(Richard Walker, Community Affairs

Officer) 600 Atlantic Avenue, Boston,

Massachusetts 02106-2204:

1. Danvers Bancorp, Inc., Danvers,

Massachusetts; to become a bank

holding company by acquiring 100

percent of the voting shares of Danvers

Savings Bank, Danvers, Massachusetts.

B. Federal Reserve Bank of

Richmond (A. Linwood Gill III,

Assistant Vice President) 701 East Byrd

Street, Richmond, Virginia 23261-4528:

1. One Valley Bancorp, Inc.,

Charleston, West Virginia; to acquire

100 percent of the voting shares of

Summit Bankshares, Inc., Raphine,

Virginia, and thereby indirectly acquire

Bank of Rockbridge, Raphine, Virginia.

C. Federal Reserve Bank of Chicago

(Philip Jackson, Applications Officer)

230 South LaSalle Street, Chicago,

Illinois 60690-1413:

1. First American Bankshares, Inc.,

Fort Atkinson, Wisconsin; to acquire

100 percent of the voting shares of

Jefferson County Bancorp, Inc.,

Jefferson, Wisconsin, and thereby

indirectly acquire Jefferson County

Bank, Jefferson, Wisconsin.

Board of Governors of the Federal Reserve

System, June 16, 1998.

Robert deV. Frierson,

Associate Secretary of the Board.

[FR Doc. 98–16423 Filed 6–19–98; 8:45 am]

BILLING CODE 6210–01–F

FEDERAL RESERVE SYSTEM

Formations of, Acquisitions by, and

Mergers of Bank Holding Companies

The companies listed in this notice

have applied to the Board for approval,

pursuant to the Bank Holding Company

Act of 1956 (12 U.S.C. 1841 et seq.)

(BHC Act), Regulation Y (12 CFR Part

225), and all other applicable statutes

and regulations to become a bank

holding company and/or to acquire the

assets or the ownership of, control of, or

the power to vote shares of a bank or

bank holding company and all of the

banks and nonbanking companies

owned by the bank holding company,

including the companies listed below.

The applications listed below, as well

as other related filings required by the

Board, are available for immediate

inspection at the Federal Reserve Bank

indicated. The application also will be

available for inspection at the offices of

the Board of Governors. Interested

persons may express their views in

writing on the standards enumerated in

the BHC Act (12 U.S.C. 1842(c)). If the

proposal also involves the acquisition of

a nonbanking company, the review also

includes whether the acquisition of the

nonbanking company complies with the

standards in section 4 of the BHC Act.

Unless otherwise noted, nonbanking

activities will be conducted throughout

the United States.

Unless otherwise noted, comments

regarding each of these applications

must be received at the Reserve Bank

indicated or the offices of the Board of

Governors not later than July 17, 1998.

A. Federal Reserve Bank of Boston

(Richard Walker, Community Affairs

Officer) 600 Atlantic Avenue, Boston,

Massachusetts 02106-2204:

1. UST Corp., Boston, Massachusetts;

to acquire and thereby merge with

Affiliated Community Bancorp,

Waltham, Massachusetts, and thereby

indirectly acquire Lexington Savings

Bank, Lexington, Massachusetts; and

Middlesex Bank & Trust Company,

Newton, Massachusetts.

In connection with this application,

Applicant also has filed to acquire the

Federal Savings Bank, Waltham,

Massachusetts, and thereby operate a

federal savings bank, pursuant to §

225.28(b)(4) of Regulation Y.

B. Federal Reserve Bank of Cleveland

(Paul Kaboth, Banking Supervisor) 1455

East Sixth Street, Cleveland, Ohio

44101-2566:

1. Second Bancorp Incorporated,

Warren, Ohio; to merge with Enfin, Inc.,

Solon, Ohio, and thereby indirectly

acquire Enterprise Bank, Solon, Ohio.

C. Federal Reserve Bank of Atlanta

(Lois Berthaume, Vice President) 104

Marietta Street, N.W., Atlanta, Georgia

30303-2713:

1. First American Corporation,

Nashville, Tennessee; to acquire 100

percent of the voting shares of The

Middle Tennessee Bank, Columbia,

Tennessee.

2. Synovus Financial Corp., and

TB&C Bancshares, Inc., both of

Columbus, Georgia; to merge with

Community Bank Capital Corporation,

Alpharetta, Georgia, and thereby

indirectly acquire Bank of North

Georgia, Alpharetta, Georgia.

D. Federal Reserve Bank of Chicago

(Philip Jackson, Applications Officer)

230 South LaSalle Street, Chicago,

Illinois 60690-1413:

1. The Connor Trusts, Marshfield,

Wisconsin; to acquire 51 percent of the

voting shares of Pioneer Bancorp, Inc.,

Auburndale, Wisconsin, and thereby

indirectly acquire Pioneer Bank,

Auburndale, Wisconsin.

E. Federal Reserve Bank of St. Louis

(Randall C. Sumner, Vice President) 411

Locust Street, St. Louis, Missouri 63102-

2034:

1. National City Bancshares, Inc.,

Evansville, Indiana; to merge with

Hoosier Hills Financial Corporation,

Osgood, Indiana, and thereby indirectly

acquire The Ripley County Bank,

Osgood, Indiana.

Board of Governors of the Federal Reserve

System, June 17, 1998.

Robert deV. Frierson,

Associate Secretary of the Board.

[FR Doc. 98–16543 Filed 6–19–98; 8:45 am]

BILLING CODE 6210–01–F

FEDERAL RESERVE SYSTEM

Notice of Proposals to Engage in

Permissible Nonbanking Activities or

to Acquire Companies that are

Engaged in Permissible Nonbanking

Activities

The companies listed in this notice

have given notice under section 4 of the

Bank Holding Company Act (12 U.S.C.

1843) (BHC Act) and Regulation Y, (12

CFR Part 225) to engage de novo, or to

acquire or control voting securities or

assets of a company, including the

companies listed below, that engages

either directly or through a subsidiary or

other company, in a nonbanking activity

that is listed in § 225.28 of Regulation

Y (12 CFR 225.28) or that the Board has

determined by Order to be closely

related to banking and permissible for

bank holding companies. Unless

otherwise noted, these activities will be

conducted throughout the United States.

Each notice is available for inspection

at the Federal Reserve Bank indicated.

The notice also will be available for

inspection at the offices of the Board of

Governors. Interested persons may

express their views in writing on the

question whether the proposal complies

with the standards of section 4 of the

BHC Act.

Unless otherwise noted, comments

regarding the applications must be

received at the Reserve Bank indicated

or the offices of the Board of Governors

not later than July 7, 1998.

A. Federal Reserve Bank of New

York (Betsy Buttrill White, Senior Vice

President) 33 Liberty Street, New York,

New York 10045-0001:

1. Deutsche Bank AG, Frankfurt am

Main, Germany; to acquire German

American Capital Corporation, New

York, New York, and thereby engage in

acquiring debt that is in default at the

time of acquisition, pursuant to §

225.28(b)(2)(vii) of Regulation Y.
Federal Register / Vol. 63, No. 119 / Monday, June 22, 1998 / Notices 33933

Board of Governors of the Federal Reserve

System, June 17, 1998.

Robert deV. Frierson,

Associate Secretary of the Board.

[FR Doc. 98–16541 Filed 6–19–98; 8:45 am]

BILLING CODE 6210–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 98N–0364]

Agency Information Collection

Activities: Proposed Collection;

Comment Request

AGENCY: Food and Drug

Administration, HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing an

opportunity for public comment on the

proposed collection of certain

information by the agency. Under the

Paperwork Reduction Act of 1995 (the

PRA), Federal agencies are required to

publish notice in the Federal Register

concerning each proposed collection of

information, including each proposed

reinstatement of an existing collection

of information, and to allow 60 days for

public comment in response to the

notice. This notice solicits comments on

product specific reports and

recordkeeping requirements for certain

electronic products.

DATES: Submit written comments on the

collection of information by August 21,

1998.

ADDRESSES: Submit written comments

on the collection of information to the

Dockets Management Branch (HFA–

305), Food and Drug Administration,

12420 Parklawn Dr., rm. 1–23,

Rockville, MD 20857. All comments

should be identified with the docket

number found in brackets in the

heading of this document.

FOR FURTHER INFORMATION CONTACT:

Margaret R. Schlosburg, Office of

Information Resources Management

(HFA–250), Food and Drug

Administration, 5600 Fishers Lane,

Rockville, MD 20857, 301–827–1223.

SUPPLEMENTARY INFORMATION: Under the

PRA (44 U.S.C. 3501–3520), Federal

agencies must obtain approval from the

Office of Management and Budget

(OMB) for each collection of

information they conduct or sponsor.

‘‘Collection of information’’ is defined

in 44 U.S.C. 3502(3) and 5 CFR

1320.3(c) and includes agency requests

or requirements that members of the

public submit reports, keep records, or

provide information to a third party.

Section 3506(c)(2)(A) of the PRA (44

U.S.C. 3506(c)(2)(A)) requires Federal

agencies to provide a 60-day notice in

the Federal Register concerning each

proposed collection of information,

including each proposed reinstatement

of an existing collection of information,

before submitting the collection to OMB

for approval. To comply with this

requirement, FDA is publishing notice

of the proposed collection of

information listed below.

With respect to the following

collection of information, FDA invites

comments on: (1) Whether the proposed

collection of information is necessary

for the proper performance of FDA’s

functions, including whether the

information will have practical utility;

(2) the accuracy of FDA’s estimate of the

burden of the proposed collection of

information, including the validity of

the methodology and assumptions used;

(3) ways to enhance the quality, utility,

and clarity of the information to be

collected; and (4) ways to minimize the

burden of the collection of information

on respondents, including through the

use of automated collection techniques,

when appropriate, and other forms of

information technology.

Reporting and Recordkeeping for

Electronic Products: Specific Product

Requirements 21 CFR Parts 1020, 1030,

1040, and 1050 (OMB Control Number

0910–0213—Reinstatement)

Under sections 532 to 542 of the

Federal Food, Drug, and Cosmetic Act

(the act) (21 U.S.C. 360ii to 360ss), FDA

has the responsibility to protect the

public from unnecessary exposure to

radiation from electronic products.

Section 532 of the act (21 U.S.C. 360ii)

directs the Secretary of the Department

of Health and Human Services (the

Secretary) to establish and carry out an

electronic product radiation control

program designed to protect the public

health and safety from electronic

radiation by, among other things,

developing and administering

performance standards for electronic

products. Section 534(g) of the act (21

U.S.C. 360kk(g)) directs the Secretary to

review and evaluate industry testing

programs on a continuing basis; and

section 535(e) and (f) of the act (21

U.S.C. 360ll(e) and (f)) directs the

Secretary to immediately notify

manufacturers of, and assure correction

of, radiation defects or noncompliance

with performance standards. The

agency’s authority to require records

and reports is contained in section

537(b) and (c) of the act (21 U.S.C.

360nn(b) and (c)).

Under this authority, FDA issued

regulations detailing product-specific

performance standards that specify

information to be supplied with the

product or require specific reports.

The information collections are either

specifically called for in the act or were

developed to aid the agency in

performing its obligations under the act.

The data reported to FDA and the

records that are maintained are used by

FDA and the industry to make decisions

and take actions that protect the public

from radiation hazards presented by

electronic products. This information

refers to the identification of, location

of, operational characteristics of, quality

assurance programs for, and problem

identification and correction of

electronic products. The data provided

to users and others are intended to

encourage actions to reduce or eliminate

radiation exposures.

The consequence of not obtaining the

required information is that the public

unknowingly may be exposed to

unnecessary radiation hazards

presented by electronic products.

Without this information, FDA could

not adequately make rational decisions

and take appropriate actions to protect

the public from these hazards as called

for in the act.

Respondents to this collection of

information are manufacturers,

importers, and assemblers of electronic

products. Not all of the requirements are

placed on all of these groups.

FDA estimates the burden of this

collection of information as follows:

TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1

21 CFR Section No. of

Respondents

Annual

Frequency per

Response

Total Annual

Responses

Hours per

Response Total Hours

1020.20(c)(4) 1 1 1 1 1

1020.30(g) 200 1.33 265 35 9,275